Avalo Therapeutics, Inc. (AVTX)

14.50 +0.21 (+1.47%) USD  |  NASDAQ  |  Apr 22, 16:00
14.50 0.00 (0.00%) After-Hours: 18:11
More

Avalo Therapeutics Price Target Num Estimates

Price Target Num Estimates Chart

View Price Target Num Estimates for AVTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Num Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Num Estimates Range, Past 5 Years

View Price Target Num Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Num Estimates Benchmarks

View Price Target Num Estimates Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
AbbVie, Inc. Upgrade
Relmada Therapeutics, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade